Draft Medical Policies


Participating providers are invited to submit for consideration scientific, evidence-based information, professional consensus opinions, and other information supported by medical literature relevant to our draft policies.

We accept comments for 45 days from the posting date listed on the draft policy. Make sure your voice is heard by providing feedback directly to us.

How to Submit Comments on Draft Medical Policies

Complete our medical policy feedback form online or send comments and supporting documentation to us by mail or fax:

Blue Cross and Blue Shield of Alabama
Attn: Health Management - Medical Policy
P.O. Box 995
Birmingham, AL 35298-0001

Fax: 205-220-0878

Current Draft Policies

Policy # Policy Title Print View
MP-045 Management of Varicose Veins
MP-128 Automated Ambulatory Blood Pressure
MP-218 Transcatheter Closure Devices for Septal Defects
MP-341 Homocysteine Testing in the Screening, Diagnosis, and Management of Cardiovascular Disease and Venous Thromboembolic Disease
MP-490 Left-Atrial Appendage Closure or Clipping
MP-543 Genetic Testing for Alpha-1 Antitrypsin Deficiency
MP-561 Transcatheter Mitral Valve Repair
MP-631 Open and Thoracoscopic Approaches to Treat Atrial Fibrillation and Atrial Flutter (Maze and Related Procedures)
MP-703 Leadless Cardiac Pacemakers
MP-730 Phrenic Nerve Stimulation for Central Sleep Apnea
MP-731 Hepatitis C Positive Organs for Transplantation to Non-Viremic Patients